Stage IV lung carcinoids: spectrum and evolution of proliferation rate, focusing on variants with elevated proliferation indices

Natasha Rekhtman(Memorial Sloan Kettering Cancer Center), Patrice Desmeules(Memorial Sloan Kettering Cancer Center), Anna Maria Litvak(Saint Barnabas Medical Center), M. Catherine Pietanza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Maria L. Santos-Zabala(Memorial Sloan Kettering Cancer Center), Ai Ni(Memorial Sloan Kettering Cancer Center), Joseph Montecalvo(Memorial Sloan Kettering Cancer Center), Jason C. Chang(Memorial Sloan Kettering Cancer Center), Amanda Beras(Memorial Sloan Kettering Cancer Center), Isabel R. Preeshagul(Memorial Sloan Kettering Cancer Center), Joshua K. Sabari(Memorial Sloan Kettering Cancer Center), Charles M. Rudin(Memorial Sloan Kettering Cancer Center), Marc Ladanyi(Memorial Sloan Kettering Cancer Center), David S. Klimstra(Memorial Sloan Kettering Cancer Center), William D. Travis(Memorial Sloan Kettering Cancer Center), W. Victoria Lai(Memorial Sloan Kettering Cancer Center)
Modern Pathology
March 28, 2019
Cited by 83Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis